当前位置:首页 - 行情中心 - 日科化学(300214) - 财务分析 - 利润表

日科化学

(300214)

  

流通市值:22.03亿  总市值:25.45亿
流通股本:4.04亿   总股本:4.66亿

利润表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、营业总收入606,662,875.552,537,774,754.221,904,805,705.851,231,972,887.65
营业收入606,662,875.552,537,774,754.221,904,805,705.851,231,972,887.65
二、营业总成本611,694,418.462,442,467,461.581,825,731,316.411,177,011,611.62
营业成本565,558,054.912,307,065,325.641,727,065,867.031,115,319,051.1
税金及附加4,017,848.0915,284,682.611,720,893.557,686,463.23
销售费用8,358,459.0834,199,169.223,690,630.8814,019,099.5
管理费用25,315,513.0946,644,615.1435,341,695.8620,846,421.71
研发费用6,763,408.4141,003,833.3629,682,146.1221,847,614.86
财务费用1,681,134.88-1,730,164.36-1,769,917.03-2,707,038.78
其中:利息费用2,569,909.425,090,937.013,159,793.992,144,073.05
其中:利息收入387,426.372,949,639.751,338,163.021,030,263.15
加:公允价值变动收益0880,644.45-0
加:投资收益831,355.1716,300,334.4814,349,920.239,732,904.43
净敞口套期收益0---
资产处置收益-47,323.19-5,625,564.8860,259.630
资产减值损失(新)0-7,767,003.12-1,367,620.87-1,635,266.89
信用减值损失(新)-2,161,119.13-3,427,080.96-3,230,471.53-1,406,645.38
其他收益459,001.85837,927.74650,604.15648,203.58
营业利润平衡项目0000
四、营业利润-5,949,628.2196,506,550.3589,537,081.0562,300,471.77
加:营业外收入356,799.35324,355.057,266,208.147,162,423
减:营业外支出168,013.311,387,393.57627,422128,140.63
利润总额平衡项目0000
五、利润总额-5,760,842.1795,443,511.8396,175,867.1969,334,754.14
减:所得税费用2,494,560.4611,107,254.1414,034,323.0411,085,949.27
六、净利润-8,255,402.6384,336,257.6982,141,544.1558,248,804.87
持续经营净利润-8,255,402.6384,336,257.6982,141,544.1558,248,804.87
归属于母公司股东的净利润-8,713,724.1384,632,655.382,348,260.4358,390,507.53
少数股东损益458,321.5-296,397.61-206,716.28-141,702.66
(一)基本每股收益-0.010.180.180.12
(二)稀释每股收益-0.010.180.180.12
九、综合收益总额-8,255,402.6384,336,257.6982,141,544.1558,248,804.87
归属于母公司股东的综合收益总额-8,713,724.1384,632,655.382,348,260.4358,390,507.53
归属于少数股东的综合收益总额458,321.5-296,397.61-206,716.28-141,702.66
公告日期2024-04-272024-04-272023-10-242023-08-31
审计意见(境内)标准无保留意见
TOP↑